Expertise France recrute un conseiller résident jumelage (H/F), Kigali, Rwanda

Description de la mission

The Resident Twinning Adviser will be based in Rwanda (Kigali) to provide full-time input and advice to the project for its entire duration (24 to 27 months). The project will be starting in September or October 2022. She/he will be in charge of the day-to-day project implementation and coordination of project activities according to a predetermined work plan and liaise with the RTA counterpart in Rwanda. (S)he should co-ordinate the project and have a certain level of understanding of all the components.

Tasks:
– To coordinate and assure project implementation and implementation of all project activities;
– To prepare the initial and subsequent work plans and project progress reports, together with the PL;
– To assure the coherence and continuity of the successive inputs and the on-going progress;
– To coordinate the activities of all team members in line with the work plan;
– To assess continuously project progress to assure its timely implementation;
– To prepare material for regular monitoring and reporting;
– To liaise with MS and Beneficiary Country (BC) PLs and maintain regular contact with the BC RTA;
– To provide technical advice, support and assistance to the Beneficiary institution in the areas specified in the work plan;
– To liaise with the EU Delegation Project Manager & Team Leader;
– To liaise with other relevant institutions in Rwanda and with other relevant projects.

Description du projet ou contexte

Rwanda has a well-articulated policy framework to guide its developmental aspirations. Rwanda’s Vision 2050 identifies the country’s overarching objectives to transform its economy and modernize the lives of Rwandans, with the aim to reach upper-middle income status by 2035 and high-income status by 2050.

In the framework of the new multi-annual indicative programme (MIP) for 2021-2027, the EU will consider support on investment promotion, including in the health and pharmaceutical sector, supporting local manufacturing and access to essential health products and technologies. In this regard strengthening of the health regulatory system will be a key component. The EU therefore intends to support the capacity of the Rwanda Food and Drug Authority (Rwanda FDA) to fully play its regulatory functions, including marketing authorisation and registration, licensing and inspection of premises, market surveillance and enforcement.

Overall Objective :

Improve the enabling environment for regulation of medicinal products and vaccines in Rwanda.

Specific objective :

The specific objective of this project is to support Rwanda Food and Drugs Authority (FDA) in developing a functional regulatory system and in building the capacity of its staff in selected key areas for the authority to regulate pharmaceutical products including vaccines.

Component 1: Improving legal framework and regulatory functions linked to medicinal products

Component 2: Strengthening of market surveillance and control function – vigilance & laboratory testing functions

Component 3: Support the establishment of the official batch release function for vaccines

Profil souhaité

Skill requirements:
– University degree in health economics, public health, public administration or other relevant discipline (such as physician, pharmacist, regulator, ..) or equivalent professional experience of 8 years in the public health sector ;
– Minimum 3 years of specific experience in human medicines related regulatory functions in EU MS relevant national administrations ;
– Very good spoken and written English (at least level 2 on a scale of 1 [excellent] to 5 [basic])

– Good coordination skills (partnerships)

– Good interpersonal skills

Assets:
– Strong experience in project management, preferably twinning ;
– Experience in implementation of relevant EU legislation and EU instruments related to the project components.

Informations complémentaires

Please send your application including :

– CV

– Cover letter

– References

 

Date limite de candidature : 03/04/2022 23:59